Gene expression in mixed type liposarcoma

References

• Fletcher C. D. M., Unni K. K., Mertens F. World Health Organization Classification of Tumors: Pathology and Genetics of Tumors of Soft Tissue and Bone. IARC Press, Lyon 2002; 35–46
   Google Scholar
• Meis‐Kindblom J. M., Sjogren H., Kindblom L. G., et al. Cytogenetic and molecular genetic analyses of liposarcoma and its soft tissue simulators: Recognition of new variants and differential diagnosis. Virchows Arch 2001; 439: 141–51
   PubMed Web of Science ®Google Scholar
• Weiss S. W., Goldblum J. R. Enzinger and Weiss's Soft Tissue Tumors. Mosby, St Louis 2001, 4th ed. Chapter 17, Liposarcoma
   Google Scholar
• Mentzel T., Fletcher C. D. M. Dedifferentiated myxoid liposarcoma: A clinico‐pathological study suggesting a closer relationship between myxoid and well differentiated liposarcoma. Histopathology 1997; 30: 457–63
   PubMed Web of Science ®Google Scholar
• Klimstra D. S., Moran C. A., Perino G., et al. Liposarcoma of the anterior mediastinum and thymus. A clinicopathologic study of 28 cases. Am J Surg Pathol 1995; 19: 782–91
   PubMed Web of Science ®Google Scholar
• Tan G. Y., Chong Y. L., Ramesh K., et al. Giant mixed‐type perinephric liposarcoma. Int Urol Nephrol 2004; 36: 319–22
   PubMedGoogle Scholar
• Irie T., Hatori M., Watanabe M., et al. Radiologically and histologically mixed liposarcoma: A report of two biphasic cases. Jpn J Clin Oncol 2003; 33: 482–5
   PubMed Web of Science ®Google Scholar
• De Cecco L., Gariboldi M., Reid J. F., et al. Gene expression profile identifies a rare epithelioid variant case of pleomorphic liposarcoma carrying FUS‐CHOP transcript. Histopathology 2005; 46: 334–41
   PubMed Web of Science ®Google Scholar
• Nakanishi H., Araki N., Joyama S., et al. Myxoid liposarcoma with adipocytic maturation: Detection of TLS/CHOP fusion gene transcript. Diagn Mol Pathol 2004; 13: 92–6
   PubMedGoogle Scholar
• Shimoji T., Kanda H., Kitagawa T., et al. Clinico‐molecular study of de‐ differentiation in well‐differentiated liposarcoma. Biochem Biophys Res Commun 2004; 314: 1133–40
   PubMed Web of Science ®Google Scholar
• Skubitz K. M., Cheng E. Y., Clohisy D. R., et al. Differential gene expression in liposarcoma, lipoma, and adipose tissue. Cancer Invest 2005; 23: 105–18
   PubMed Web of Science ®Google Scholar
• Sotiriou C., Neo S. Y., McShane L. M., et al. Breast cancer classification and prognosis based on gene expression profiles from a population‐based study. Proc Natl Acad Sci USA 2003; 100: 10393–8
   PubMed Web of Science ®Google Scholar
• Hegde P., Qi R., Gaspard R., et al. Identification of tumor markers in models of human colorectal cancer using a 19,200‐element complementary DNA microarray. Cancer Res 2001; 61: 7792–7
   PubMed Web of Science ®Google Scholar
• Alizadeh A. A., Eisen M. B., Davis R. E., et al. Distinct types of diffuse large B‐cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503–11
   PubMed Web of Science ®Google Scholar
• Tallini G., Akerman M., Dal Cin P., et al. Combined morphologic and karyotypic study of 28 myxoid liposarcomas. implications for a revised morphologic typing (a report from the CHAMP group). Am J Surg Pathol 1996; 20: 1047–55
   PubMed Web of Science ®Google Scholar
• Gebhard S., Coindre J. M., Michels J. J., et al. Pleomorphic liposarcoma: Clinicopathologic, immunohistochemical, and follow‐up analysis of 63 cases: A study from the french federation of cancer centers sarcoma group. Am J Surg Pathol 2002; 26: 601–16
   PubMed Web of Science ®Google Scholar
• Hashimoto H., Daimaru Y., Enjoji M. S‐100 protein distribution in liposarcoma. an immunoperoxidase study with special reference to the distinction of liposarcoma from myxoid malignant fibrous histiocytoma. Virchows Arch A Pathol Anat Histopathol 1984; 405: 1–10
   PubMedGoogle Scholar
• Pilotti S., Della Torre G., Lavarino C., et al. Distinct mdm2/p53 expression patterns in liposarcoma subgroups: Implications for different pathogenetic mechanisms. J Pathol 1997; 181: 14–24
   PubMed Web of Science ®Google Scholar
• Dei Tos A. P., Doglioni C., Piccinin S., et al. Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma. J Pathol 1997; 181: 8–13
   PubMed Web of Science ®Google Scholar
• Tamborini E., Della Torre G., Lavarino C., et al. Analysis of the molecular species generated by MDM2 gene amplification in liposarcomas. Int J Cancer 2001; 92: 790–6
   PubMed Web of Science ®Google Scholar
• Vider B. Z., Zimber A., Hirsch D., et al. Human colorectal carcinogenesis is associated with deregulation of homeobox gene expression. Biochem Biophys Res Commun 1997; 232: 742–8
   PubMed Web of Science ®Google Scholar
• Xia X., Cheng A., Lessor T., et al. Ebp1, an ErbB‐3 binding protein, interacts with rb and affects rb transcriptional regulation. J Cell Physiol 2001; 187: 209–17
   PubMed Web of Science ®Google Scholar
• Idbaih A., Coindre J. M., Derre J., et al. Myxoid malignant fibrous histiocytoma and pleomorphic liposarcoma share very similar genomic imbalances. Lab Invest 2005; 85: 176–81
   PubMed Web of Science ®Google Scholar
• Rieker R. J., Joos S., Bartsch C., et al. Distinct chromosomal imbalances in pleomorphic and in high‐grade dedifferentiated liposarcomas. Int J Cancer 2002; 99: 68–73
   PubMed Web of Science ®Google Scholar
• Kanekura T., Chen X., Kanzaki T. Basigin (CD147) is expressed on melanoma cells and induces tumor cell invasion by stimulating production of matrix metalloproteinases by fibroblasts. Int J Cancer 2002; 99: 520–8
   PubMed Web of Science ®Google Scholar
• Kato N., Fukase M., Motoyama T. Expression of a transcription factor, SOX9, in sertoli‐stromal cell tumors of the ovary. Int J Gynecol Pathol 2004; 23: 180–1
   PubMed Web of Science ®Google Scholar
• Abe N., Watanabe T., Izumisato Y., et al. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: Its potential use in the diagnosis of liver neoplasms. J Gastroenterol 2003; 38: 1144–9
   PubMed Web of Science ®Google Scholar
• Pierantoni G. M., Battista S., Pentimalli F., et al. A truncated HMGA1 gene induces proliferation of the 3T3‐L1 pre‐adipocytic cells: A model of human lipomas. Carcinogenesis 2003; 24: 1861–9
   PubMed Web of Science ®Google Scholar
• Allenspach E. J., Maillard I., Aster J. C., et al. Notch signaling in cancer. Cancer Biol Ther 2002; 1: 466–76
   PubMed Web of Science ®Google Scholar
• Wen C. Y., Nakayama T., Wang A. P., et al. Expression of pituitary tumor transforming gene in human gastric carcinoma. World J Gastroenterol 2004; 10: 481–3
   PubMed Web of Science ®Google Scholar
• Aggarwal B. B., Bhardwaj A., Aggarwal R. S., et al. Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies. Anticancer Res 2004; 24: 2783–840
   PubMed Web of Science ®Google Scholar
• Das R., Hammamieh R., Neill R., et al. Expression pattern of fatty acid‐binding proteins in human normal and cancer prostate cells and tissues. Clin Cancer Res 2001; 7: 1706–15
   PubMed Web of Science ®Google Scholar
• Kubista B., Erovic B. M., Klinger H., et al. CD9 expression is not a prognostic factor in human osteosarcoma. Cancer Lett 2004; 209: 105–10
   PubMed Web of Science ®Google Scholar
• Bassi D. E., Mahloogi H., Lopez De Cicco R., et al. Increased furin activity enhances the malignant phenotype of human head and neck cancer cells. Am J Pathol 2003; 162: 439–47
   PubMed Web of Science ®Google Scholar
• Forough R., Lindner L., Partridge C., et al. Elevated 80K‐H protein in breast cancer: A role for FGF‐1 stimulation of 80K‐H. Int J Biol Markers 2003; 18: 89–98
   PubMed Web of Science ®Google Scholar
• Brennan P. A., Jing J., Ethunandan M., et al. Dystroglycan complex in cancer. Eur J Surg Oncol 2004; 30: 589–92
   PubMed Web of Science ®Google Scholar
• Barthlen W., Flaadt D., Girgert R., et al. Significance of heparin‐binding growth factor expression on cells of solid pediatric tumors. J Pediatr Surg 2003; 38: 1296–304
   PubMed Web of Science ®Google Scholar
• Ishikawa M., Kitayama J., Kazama S., et al. The expression pattern of vascular endothelial growth factor C and D in human esophageal normal mucosa, dysplasia and neoplasia. Hepatogastroenterology 2004; 51: 1319–22
   PubMedGoogle Scholar
• Douglas M. L., Richardson M. M., Nicol D. L. Endothelin axis expression is markedly different in the two main subtypes of renal cell carcinoma. Cancer 2004; 100: 2118–24
   PubMed Web of Science ®Google Scholar